Florida health officials are raising alarms about the safety of the newest versions of mRNA COVID-19 vaccines, advising ...

Results from the first-in-human trial of a new mRNA-based cancer vaccine are promising, as are early results from two other ...

We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

I am deeply troubled by the growing distrust of science in our society, just at the time when its insights are most needed.

Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc.

Japan's health ministry has approved five types of coronavirus vaccines for use in this season's campaign that starts on October 1.

ME Therapeutics to begin testing of first mRNA formulations from NanoVation Therapeutics collaboration: Vancouver, British Columbia Friday, September 20, 2024, 14:00 Hrs [IST] ME ...

Even as the Covid wave in Florida continues, Gov. Ron DeSantis’ administration is once again advising against the mRNA ...

Present Market Standing of Moderna Trading volume stands at 5,013,059, with MRNA's price down by -2.52%, positioned at $68.1. RSI indicators show the stock to be may be approaching oversold. Earnings ...